Microbiota-Derived Short-Chain Fatty Acids Promote BMP Signaling by Inhibiting Histone Deacetylation and Contribute to Dentinogenic Differentiation in Murine Incisor Regeneration-Reference-Cited by-同舟云学术

Microbiota-Derived Short-Chain Fatty Acids Promote BMP Signaling by Inhibiting Histone Deacetylation and Contribute to Dentinogenic Differentiation in Murine Incisor Regeneration

Published:2020-09-15 Issue:18 Volume:29 Page:1201-1214
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Ren Yi¹,Su Shenping¹,Liu Xingyu¹,Zhang Yi²,Zhao Yuming¹,Xiao E.²³

Affiliation:

1. Department of Pediatric Dentistry, and Peking University School and Hospital of Stomatology, Beijing, China.

2. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.

3. Department of Stomatology, First People's Hospital of Jinzhong, Jinzhong, China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2020.0057

Reference51 articles.

1. Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation

2. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss

3. Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling

4. Effects of the gut microbiota on bone mass

5. Host microbiota constantly control maturation and function of microglia in the CNS

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models and related techniques for dentin study;Odontology;2024-09-03

2. Microbiota and Resveratrol: How Are They Linked to Osteoporosis?;Cells;2024-07-03

3. Potential Role of BMP7 in Regenerative Dentistry;International Dental Journal;2024-04

4. Role of mesenchymal stem cells and short chain fatty acids in allergy: A prophylactic therapy for future;Immunology Letters;2023-08

5. Microbiome therapeutics for the cancer management;Microbiome Therapeutics;2023